The role of infectious agents in the pathogenesis of vasculitis

Nicolò Pipitone, Carlo Salvarani, Nicolò Pipitone, Carlo Salvarani

Abstract

Numerous human studies and animal models have implicated various infectious agents in the pathogenesis of vasculitis in susceptible hosts. However, the link between infection and vasculitis is very complex and only incompletely understood. In fact, different agents can induce the same type of vasculitis, as the case of leukocytoclastic vasculitis exemplifies. Conversely, the same agent can give rise to a panoply of host responses ranging from a clinically silent infection or localized organ involvement to devastating, widespread vasculitis.

References

    1. Scott D.G., Watts R.A. Classification and epidemiology of systemic vasculitis. British Journal of Rheumatology. 1994;33:897–899.
    1. Mohan N., Kerr G. Infectious etiology of vasculitis: diagnosis and management. Current Rheumatology Reports. 2003;5:136–141.
    1. Oldstone M.B. Molecular mimicry and immune-mediated diseases. The FASEB Journal. 1998;12:1255–1265.
    1. Rodriguez-Pla A., Stone J.H. Vasculitis and systemic infections. Current Opinion in Rheumatology. 2006;18:39–47.
    1. Dal Canto A.J., Virgin H.W. Animal models of infection-mediated vasculitis. Current Opinion in Rheumatology. 1999;11:17–23.
    1. Fong I.W., Chiu B., Viira E. Rabbit model for Chlamydia pneumoniae infection. Journal of Clinical Microbiology. 1997;35:48–52.
    1. Esteban M.J., Font C., Hernandez-Rodriguez J. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients. Arthritis and Rheumatism. 2001;44:1387–1395.
    1. Thibault S., Drolet R., Germain M.C. Cutaneous and systemic necrotizing vasculitis in swine. Veterinary Pathology. 1998;35:108–116.
    1. Dangler C.A., Baker S.E., Kariuki N.M., Chia S.H. Murine cytomegalovirus-associated arteritis. Veterinary Pathology. 1995;32:127–133.
    1. Berencsi K., Endresz V., Klurfeld D. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell Adhesion and Communication. 1998;5:39–47.
    1. Persoons M.C., Stals F.S., dam Mieras M.C., Bruggeman C.A. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. The Journal of Pathology. 1998;184:103–109.
    1. Golden M.P., Hammer S.M., Wanke C.A., Albrecht M.A. Cytomegalovirus vasculitis. Case reports and review of the literature. Medicine. 1994;73:246–255.
    1. Presti R.M., Pollock J.L., Dal Canto A.J. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. The Journal of Experimental Medicine. 1998;188:577–588.
    1. Weck K.E., Dal Canto A.J., Gould J.D. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nature Medicine. 1997;3:1346–1353.
    1. Nicklin M.J., Hughes D.E., Barton J.L. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. The Journal of Experimental Medicine. 2000;191:303–312.
    1. Sohn S., Lee E.S., Bang D., Lee S. Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. European Journal of Dermatology. 1998;8:21–23.
    1. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335:1078–1080.
    1. Tinkle B.T., Ngo L., Luciw P.A. Human immunodeficiency virus-associated vasculopathy in transgenic mice. Journal of Virology. 1997;71:4809–4814.
    1. Terada L.S., Gu Y., Flores S.C. AIDS vasculopathy. The American Journal of the Medical Sciences. 2000;320:379–387.
    1. Gherardi R., Belec L., Mhiri C. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis and Rheumatism. 1993;36:1164–1174.
    1. Malavolta Luiz Caetano, Bechara Milton Jacob. Infectious arteritis. Problems in General Surgery. 2001;18:88–91.
    1. Frank M.W., Mehlman D.J., Tsai F. Syphilitic aortitis. Circulation. 1999;100:1582–1583.
    1. Pagnoux C., Cohen P., Guillevin L. Vasculitides secondary to infections. Clinical and Experimental Rheumatology. 2006;24:S71–S81.
    1. Tavora F., Burke A. Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology. 2006;38:302–308.
    1. Yokoi M., Kase M. Retinal vasculitis due to secondary syphilis. Japanese Journal of Ophthalmology. 2004;48:65–67.
    1. Gaa J., Weidauer S., Sitzer M. Cerebral vasculitis due to Treponema pallidum infection: MRI and MRA findings. European Radiology. 2004;14:746–747.
    1. Gajaraj A., Victor S. Tuberculous aortoarteritis. Clinical Radiology. 1981;32:461–466.
    1. O'Regan A.W., Castro C., Lukehart S.A. Barking up the wrong tree? Use of polymerase chain reaction to diagnose syphilitic aortitis. Thorax. 2002;57:917–918.
    1. Bacourt F., Goeau-Brissonniere O., Lacombe P. Surgical treatment of a tuberculous thoracoabdominal aneurysm. Annals of Vascular Surgery. 1986;1:378–381.
    1. Shah S.M., Howard R.S., Sarkies N.J., Graham E.M. Tuberculosis presenting as retinal vasculitis. Journal of the Royal Society of Medicine. 1988;81:232–233.
    1. Mahr A., Guillevin L., Poissonnet M., Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis and Rheumatism. 2004;51:92–99.
    1. Guillevin L., Lhote F., Cohen P. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine. 1995;74:238–253.
    1. Naouri M., Bacq Y., Machet M.C. Interferon-alpha and ribavirin treatment in a patient with hepatitis C virus-associated cutaneous periarteritis nodosaAnnales de Dermatologie et de Vénéréologie. 2006;133:679–682.
    1. Lormeau C., Falgarone G., Roulot D., Boissier M.C. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine. 2006;73:633–638.
    1. Cacoub P., Renou C., Rosenthal E. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine. 2000;79:47–56.
    1. Lamprecht P., Gause A., Gross W.L. Cryoglobulinemic vasculitis. Arthritis and Rheumatism. 1999;42:2507–2516.
    1. Roccatello D., Baldovino S., Rossi D. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrology, Dialysis, Transplantation. 2004;19:3054–3061.
    1. Chetty R. Vasculitides associated with HIV infection. Journal of Clinical Pathology. 2001;54:275–278.
    1. Kaye B.R. Rheumatologic manifestations of HIV infections. Clinical Reviews in Allergy & Immunology. 1996;14:385–416.
    1. Font C., Miro O., Pedrol E. Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature. British Journal of Rheumatology. 1996;35:796–799.
    1. Massari M., Salvarani C., Portioli I. Polyarteritis nodosa and HIV infection: no evidence of a direct pathogenic role of HIV. Infection. 1996;24:159–161.
    1. Chetty R., Batitang S., Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Human Pathology. 2000;31:374–379.
    1. Roh S.S., Gertner E. Digital necrosis in acquired immune deficiency syndrome vasculopathy treated with recombinant tissue plasminogen activator. The Journal of Rheumatology. 1997;24:2258–2261.
    1. Calabrese L.H., Estes M., Yen-Lieberman B. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis and Rheumatism. 1989;32:569–576.
    1. Garcia-Garcia J.A., Macias J., Castellanos V. Necrotizing granulomatous vasculitis in advanced HIV infection. The Journal of Infection. 2003;47:333–335.
    1. Gillams A.R., Allen E., Hrieb K. Cerebral infarction in patients with AIDS. AJNR. American Journal of Neuroradiology. 1997;18:1581–1585.
    1. Calabrese L.H., Kirchner E., Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Seminars in Arthritis and Rheumatism. 2005;35:166–174.
    1. Reveille J.D., Williams F.M. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Practice & Research. Clinical Rheumatology. 2006;20:1159–1179.
    1. Massabki P.S., Accetturi C., Nishie I.A. Clinical implications of autoantibodies in HIV infection. AIDS (London, England) 1997;11:1845–1850.
    1. Klaassen R.J., Goldschmeding R., Dolman K.M. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clinical and Experimental Immunology. 1992;87:24–30.
    1. Gisselbrecht M., Cohen P., Lortholary O. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Annales de Médecine Interne. 1998;149:398–405.
    1. Salvarani C., Gabriel S.E., O'Fallon W.M., Hunder G.G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Annals of Internal Medicine. 1995;123:192–194.
    1. Ma-Krupa W., Jeon M.S., Spoerl S. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. The Journal of Experimental Medicine. 2004;199:173–183.
    1. Rimenti G., Blasi F., Cosentini R. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. The Journal of Rheumatology. 2000;27:2718–2720.
    1. Wagner A.D., Gerard H.C., Fresemann T. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis and Rheumatism. 2000;43:1543–1551.
    1. Regan M.J., Wood B.J., Hsieh Y.H. Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis and Rheumatism. 2002;46:1056–1060.
    1. Helweg-Larsen J., Tarp B., Obel N., Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford, England) 2002;41:445–449.
    1. Mitchell B.M., Font R.L. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Investigative Ophthalmology & Visual Science. 2001;42:2572–2577.
    1. Rodriguez-Pla A., Bosch-Gil J.A., Echevarria-Mayo J.E. No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. Journal of Clinical Virology. 2004;31:11–15.
    1. Staud R., Corman L.C. Association of parvovirus B19 infection with giant cell arteritis. Clinical Infectious Diseases. 1996;22:1123.
    1. Gabriel S.E., Espy M., Erdman D.D. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis and Rheumatism. 1999;42:1255–1258.
    1. Salvarani C., Farnetti E., Casali B. Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study. Arthritis and Rheumatism. 2002;46:3099–3101.
    1. Aggarwal A., Chag M., Sinha N., Naik S. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. International Journal of Cardiology. 1996;55:49–55.
    1. Popa E.R., Stegeman C.A., Kallenberg C.G., Tervaert J.W. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Research. 2002;4:77–79.
    1. Stegeman C.A., Tervaert J.W., de Jong P.E., Kallenberg C.G. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. The New England Journal of Medicine. 1996;335:16–20.
    1. Esper F., Shapiro E.D., Weibel C. Association between a novel human coronavirus and Kawasaki disease. The Journal of Infectious Diseases. 2005;191:499–502.
    1. Cacoub P., Saadoun D., Limal N. Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS (London, England) 2005;19(Suppl. 3):S128–S134.
    1. Bilge I., Sadikoglu B., Emre S. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatric Nephrology (Berlin, Germany) 2005;20:529–533.
    1. Ovetchkine P., Brugieres P., Seradj A. An 8-y-old boy with acute stroke and radiological signs of cerebral vasculitis after recent Mycoplasma pneumoniae infection. Scandinavian Journal of Infectious Diseases. 2002;34:307–309.
    1. Heinrich A., Khaw A.V., Ahrens N. Cerebral vasculitis as the only manifestation of Borrelia burgdorferi infection in a 17-year-old patient with basal ganglia infarction. European Neurology. 2003;50:109–112.
    1. Younger D.S. Vasculitis of the nervous system. Current Opinion in Neurology. 2004;17:317–336.
    1. Zouboulis C.C., May T. Pathogenesis of Adamantiades-Behcet's disease. Medical Microbiology and Immunology (Berlin) 2003;192:149–155.
    1. Mizushima Y., Matsuda T., Hoshi K., Ohno S. Induction of Behcet's disease symptoms after dental treatment and streptococcal antigen skin test. The Journal of Rheumatology. 1988;15:1029–1030.
    1. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Annals of the Rheumatic Diseases. 2001;60:996–1002.
    1. Direskeneli H., Saruhan-Direskeneli G. The role of heat shock proteins in Behcet's disease. Clinical and Experimental Rheumatology. 2003;21:S44–S48.
    1. Stanford M., Whittall T., Bergmeier L.A. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clinical and Experimental Immunology. 2004;137:201–208.
    1. Jessop S.J. Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. British Journal of Rheumatology. 1995;34:942–945.
    1. Naides S.J. Known causes of vasculitis in man. Cleveland Clinic Journal of Medicine. 2002;69(Suppl. 2):SII15–SII19.
    1. Kanai K., Kuwabara S., Mori M. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle & Nerve. 2003;27:113–116.
    1. Ban S., Goto Y., Kamada K. Systemic granulomatous arteritis associated with Epstein-Barr virus infection. Virchows Archiv. 1999;434:249–254.
    1. Murakami K., Ohsawa M., Hu S.X. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis and Rheumatism. 1998;41:369–373.
    1. Nakagawa A., Ito M., Iwaki T. Chronic active Epstein-Barr virus infection with giant coronary aneurysms. American Journal of Clinical Pathology. 1996;105:733–736.
    1. Dutz J.P., Benoit L., Wang X. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood. 2001;97:95–100.
    1. Sackier J.M., Kelly S.B., Clarke D. Small bowel haemorrhage due to cytomegalovirus vasculitis. Gut. 1991;32:1419–1420.
    1. Meyer M.F., Hellmich B., Kotterba S., Schatz H. Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection? Rheumatology International. 2000;20:35–38.
    1. Merle H., Donnio A., Gonin C. Retinal vasculitis caused by adult T-cell leukemia/lymphoma. Japanese Journal of Ophthalmology. 2005;49:41–45.
    1. Marmor M., Hertzmark K., Thomas S.M. Resistance to HIV infection. Journal of Urban Health. 2006;83:5–17.
    1. Patti J.M., Allen B.L., McGavin M.J., Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annual Review of Microbiology. 1994;48:585–617.
    1. Patti J.M., Bremell T., Krajewska-Pietrasik D. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infection and Immunity. 1994;62:152–161.
    1. Zhou Y.F., Shou M., Guetta E. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999;100:1569–1575.
    1. Virgin H.W. Immune regulation of viral infection and vice versa. Immunologic Research. 2005;32:293–315.
    1. Steed A., Buch T., Waisman A., Virgin H.W. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. Journal of Virology. 2007;81:6134–6140.
    1. Hoffman G.S. Large-vessel vasculitis: unresolved issues. Arthritis and Rheumatism. 2003;48:2406–2414.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir